Astrana Health ASTH Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Astrana Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Astrana Health's cash & equivalents?
- Astrana Health (ASTH) reported cash & equivalents of $478.38M in Q1 2026.
- How has Astrana Health's cash & equivalents changed year-over-year?
- Astrana Health's cash & equivalents increased by 85.0% year-over-year, from $258.52M to $478.38M.
- What is the long-term trend for Astrana Health's cash & equivalents?
- Over 5 years (2020 to 2025), Astrana Health's cash & equivalents has grown at a 17.2% compound annual growth rate (CAGR), from $193.97M to $429.47M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.